Antimicrobial Resistance and Infection Control (Jun 2020)

Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

  • Hector Felipe Garcia-Jeldes,
  • Robyn Mitchell,
  • Allison McGeer,
  • Wallis Rudnick,
  • Kanchana Amaratunga,
  • Snigdha Vallabhaneni,
  • Shawn R. Lockhart,
  • CNISP C. auris Interest Group,
  • Amrita Bharat

DOI
https://doi.org/10.1186/s13756-020-00752-3
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 5

Abstract

Read online

Abstract To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.

Keywords